Emergence Therapeutics
Emergence Therapeutics creates effective immuno-therapeutics to target Nectin-4 and other cancers.
est. 2019 · Duisburg, Germany
Zymeworks Inc.
Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases.
264 employees · est. 2003 · Canada
Zymeworks Inc. is the older company (2019 vs 2003).
Side-by-Side Comparison
| Metric | Emergence Therapeutics | Zymeworks Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2003 older |
| Headquarters | ||
| Headquarters | Duisburg, Germany | Canada |
| Employees | ||
| Employees | Not tracked yet | 264 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | IPO |
| Total Funding | ||
| Total Funding | $87.00M | $867.80M |
| Funding Rounds | ||
| Funding Rounds | 1 | 17 |
| Services | ||
| Services | Manufacture and distribution of authentic medicines, LillyDirect online pharmacy services, Conducting and supporting clinical trials, Providing informational resources on various health conditions, Developing genetic medicine treatments | Development of novel medicines, Management of healthcare assets, Partnership integration, Proprietary platform utilization |
| Target Customers | ||
| Target Customers | Patients with specific medical conditions, Healthcare providers, Individuals participating in clinical trials, Individuals seeking information on health conditions, Caregivers of patients with conditions like Alzheimer's | Patients with difficult-to-treat diseases, Healthcare providers, Pharmaceutical partners, Biotechnology researchers |
| Taxonomy | ||
| Taxonomy | Immuno-therapeutics, Antibody-drug Conjugates, Nectin-4 Targeting, Cancer Treatment, Biopharmaceutical, Linker And Payload Technology, High-priority Cancers, Therapeutic Development, Oncology, Clinical Validation, Enfortumab Vedotin, Urothelial Cancer, Innovation In ADCs, Unmet Therapeutic Needs | Antibody Therapeutics, Cancer Treatment, Autoimmune Diseases, Inflammatory Diseases, Protein Engineering, Antibody-drug Conjugates, Bispecific Antibodies, Multispecific Antibodies, Computational Biotechnology, Molecular Modeling, High-performance Computing, Protein Optimization, R&D Partnerships, Biologics Drug Discovery |
| Website | ||
| Website | emergencetx.com | zymeworks.com |
About Emergence Therapeutics
Emergence Therapeutics, established in 2019, is a prominent European biopharmaceutical company based in Germany. The company specializes in creating advanced antibody-drug conjugates (ADCs) targeting high-priority cancers, particularly through the innovation of effective immuno-therapeutics for Nect...
About Zymeworks Inc.
Zymeworks Inc. is a seasoned player in the biotechnology and health and wellness industries, founded in 2003 and headquartered in Canada. The company is committed to innovating medicine development for hard-to-treat cancers and serious diseases, as reflected in their slogan: "Developing novel medici...
We will tell you when either one moves
BounceWatch watches Emergence Therapeutics and Zymeworks Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Emergence Therapeutics and Zymeworks Inc. — by email.
Frequently Asked Questions
Compare Emergence Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Emergence Therapeutics on 14 May 2026, and Zymeworks Inc. on 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.